U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
3327133271A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular HypertensionRecruitingNo Results AvailableOpen Angle Glaucoma|Ocular HypertensionDrug: VS101 Insert Dose A|Drug: VS101 Insert Dose B|Drug: VS101 Insert Dose C|Drug: Latanoprost 0.005% eye dropshttps://ClinicalTrials.gov/show/NCT02129673
3327233272Comparator Study of the Effect of DRM04B and DRM 04 in Subjects With Axillary HyperhidrosisCompletedNo Results AvailableHyperhidrosisDrug: Dose 1 of DRM04B|Drug: Dose 2 of DRM04B|Drug: Dose 1 of DRM04|Drug: Dose 2 of DRM04|Other: Vehiclehttps://ClinicalTrials.gov/show/NCT02129660
3327333273Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular SchwannomasRecruitingNo Results AvailableNeurofibromatosis Type 2|Vestibular SchwannomasDrug: Axitinibhttps://ClinicalTrials.gov/show/NCT02129647
3327433274Singapore INfra-Genicular Angioplasty With PAclitaxel-eluting Balloon for Critical Limb Ischaemia (SINGA-PACLI) TrialRecruitingNo Results AvailablePeripheral Arterial DiseaseDevice: CB-PTA|Device: DEB-PTAhttps://ClinicalTrials.gov/show/NCT02129634
3327533275Search of Biomarkers of Mineralocorticoid Receiver Activity : the Value of Neutrophil Gelatinase Associated Lipocalin (NGAL)in Serum or Urine in HumanCompletedNo Results AvailableCardiovascular DiseasesProcedure: Urinary and blood lipococalin levels determination|Drug: Spironolactonehttps://ClinicalTrials.gov/show/NCT02129621
3327633276Low Level Laser Treatment (LLLT) and Lorcaserin for Weight ManagementActive, not recruitingNo Results AvailableOverweight|ObeseDevice: LLLT|Drug: Lorcaserinhttps://ClinicalTrials.gov/show/NCT02129608
3327733277Resveratrol and First-degree Relatives of Type 2 Diabetic PatientsRecruitingNo Results AvailablePre-diabetesDietary Supplement: placebo|Dietary Supplement: resveratrolhttps://ClinicalTrials.gov/show/NCT02129595
3327833278Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic MalignanciesRecruitingNo Results AvailableAcute Myeloid Leukemia|Hematologic Malignancies|Acute Lymphocytic Leukemia|Non Hodgkin Lymphoma|Hodgkin Lymphoma,|Multiple Myeloma|Myelodysplastic Syndrome|Chronic Lymphocytic Leukemia|Chronic Myeloid Leukemia|Myelofibrosis|Myeloproliferative SyndromeRadiation: total marrow irradiation|Drug: fludarabine phosphate|Drug: busulfan|Procedure: myeloid progenitor cell transplantation|Biological: anti-thymocyte globulin|Drug: tacrolimus|Drug: methotrexate|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT02129582
3327933279Psychoeducational and Behavioral Strategies in Reducing Distress and Anxiety in Patients With Multiple Myeloma and Their Family CaregiversActive, not recruitingNo Results AvailableMultiple MyelomaOther: Psychoeducational intervention|Behavioral: behavioral intervention|Other: counseling intervention|Other: educational intervention|Other: telephone-based intervention|Other: questionnaire administration|Other: quality-of-life assessmenthttps://ClinicalTrials.gov/show/NCT02129569
3328033280Anti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast CancerRecruitingNo Results AvailableMetastatic Breast CancerDrug: MK-3475https://ClinicalTrials.gov/show/NCT02129556
3328133281Immune Reconstitution in Stem Cell Transplant RecipientsRecruitingNo Results AvailableCancerProcedure: Blood Drawhttps://ClinicalTrials.gov/show/NCT02129543
3328233282Effect of Community Social Mobilization for the Prevention of HIV in Young South African WomenActive, not recruitingNo Results AvailableGender RelationsBehavioral: Community Social Mobilization programhttps://ClinicalTrials.gov/show/NCT02129530
3328333283Web-Based Tailored Educational Program in Improving Nurse Communication With Patients About Clinical TrialsRecruitingNo Results AvailableHealthy, no Evidence of DiseaseOther: IMPACT intervention|Other: Online education materials|Other: survey administrationhttps://ClinicalTrials.gov/show/NCT02129517
3328433284Two Techniques for Root Coverage With a Xenogeneic Collagen MatrixCompletedNo Results AvailableGingival RecessionDevice: root coverage comparing two techniqueshttps://ClinicalTrials.gov/show/NCT02129504
3328533285National Egyptian Network Pediatric Stroke and Hemiplegia RegistryRecruitingNo Results AvailableStroke With Hemiparesis|Perinatal Stroke|Focal Neurologic Deficitshttps://ClinicalTrials.gov/show/NCT02129491
3328633286Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility StudyRecruitingNo Results AvailableChemotherapy-induced Nausea and VomitingDrug: Olanzapinehttps://ClinicalTrials.gov/show/NCT02129478
3328733287Immunological Characteristics of Maternal-fetal Transmission of Cytomegalovirus in PregnancyRecruitingNo Results AvailablePregnancy|Cytomegalovirus Infections|Congenital Infectionhttps://ClinicalTrials.gov/show/NCT02129465
3328833288Olfactory Neuroepithelial Tissue of Alzheimer DiseaseCompletedNo Results AvailableAlzheimer Diseasehttps://ClinicalTrials.gov/show/NCT02129452
3328933289Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis PatientsRecruitingNo Results AvailableColitis, UlcerativeDrug: SB012|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02129439
3329033290Comparison of Outcomes During MRI Sedation With Midazolam-dexmedetomidine Versus Ketamine-dexmedetomidineRecruitingNo Results AvailableSedationDrug: Ketamine|Drug: Midazolam|Drug: Dexmedetomidinehttps://ClinicalTrials.gov/show/NCT02129426
3329133291Safety Study of Carotid Body Neurostimulation to Treat Cerebral VasospasmRecruitingNo Results AvailableAneurysmal Subarachnoid Hemorrhage|Cerebral VasospasmDevice: Delta systemhttps://ClinicalTrials.gov/show/NCT02129413
3329233292Influence on Erythropoetin-level by XenonTerminatedNo Results AvailableHealthy VolunteersDrug: Xenon pro Anaesthesia 100 % (V/V)|Drug: Aer medicinalis Linde 100%https://ClinicalTrials.gov/show/NCT02129400
3329333293EEG & Behavioral Predictors of Changes in Smoking Trajectories in Young Light SmokersRecruitingNo Results AvailableNicotine Dependencehttps://ClinicalTrials.gov/show/NCT02129387
3329433294Direct Repair Surgery for Spondylolysis of Lumbar in Young PopulationCompletedNo Results AvailableSpondylolysisProcedure: Direct repair of pars defecthttps://ClinicalTrials.gov/show/NCT02129374
3329533295Screening and Brief Intervention for Substance Misuse Following Traumatic Brain InjuryEnrolling by invitationNo Results AvailableTraumatic Brain InjuryBehavioral: Adapted Screening and Brief Intervention (Adapted SBI)|Behavioral: Screening & Education Attention Controlhttps://ClinicalTrials.gov/show/NCT02129361
3329633296Treatment of Psychosis and Agitation in Alzheimer's DiseaseRecruitingNo Results AvailableAlzheimer's Disease|Psychosis|AgitationDrug: Lithium|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02129348
3329733297Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close PartnerRecruitingNo Results AvailableNeoplasms|GlioblastomaOther: stresshttps://ClinicalTrials.gov/show/NCT02129335
3329833298Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1Not yet recruitingNo Results AvailableHepatocellular CarcinomaDrug: Sorafenib|Drug: S-1|Drug: Oxaliplatinhttps://ClinicalTrials.gov/show/NCT02129322
3329933299Haemodynamic Effects of Apelin Agonists and Antagonists in Man in COPD With Raised Pulmonary Artery PressuresCompletedNo Results AvailableCOPD|Pulmonary HypertensionProcedure: Forearm plethysmography|Procedure: Haemodynamic studieshttps://ClinicalTrials.gov/show/NCT02129309
3330033300Intragastric Balloon, Air Versus Fluid Filled: Randomized Prospective StudyRecruitingNo Results AvailableMorbid Obesity|Weight Loss|ToleranceDevice: Air filled balloon|Device: Bioenteric BIB® balloonhttps://ClinicalTrials.gov/show/NCT02129296

* Görseller ve İçerik tekif hakkına sahip olabilir